LEXINGTON, Mass. & BURLINGTON, Vt.--(BUSINESS WIRE)--MC10, Inc., the developer of BioStamp nPoint, an end-to-end system for physiological data collection and analytics, announced today a collaboration with the University of Vermont, a leading academic research institution. This initiative will utilize BioStamp nPoint’s biometric data captured from the lower limbs and the University of Vermont’s biomedical engineering and data science capabilities in creating methods to quantitatively track and analyze changes in gait patterns across a spectrum of disorders, including Huntington’s Disease.
“One’s ability or inability to walk has long been recognized as a key aspect of their health status. Recent advances in objective gait analysis have led to metrics such as gait speed being described as the ‘sixth vital sign,’” commented Dr. Arthur Combs, MD, MC10’s Chief Medical Officer. “In the past, evaluation of gait impairment has largely been subjective, instantaneous, and assessed in a laboratory. The use of BioStamp nPoint will allow researchers to monitor a patient’s gait continuously as they go about their daily lives enabling a better understanding of the patient’s health status.”
The Principal Investigator for this collaboration is Ryan McGinnis, Ph.D., an Assistant Professor in the Department of Electrical and Biomedical Engineering and Director of the M-Sense Research Group. Dr. McGinnis is a former employee of MC10 and was instrumental in the development of the fundamental algorithms of the BioStamp platform. At the University of Vermont, Dr. McGinnis continues his work with the BioStamp system with research programs focused on developing new ways to track symptom progression in neurological disorders and measure human biomechanics outside of the laboratory.
“Movement disorders, particularly Huntington’s Disease, are understudied and need better characterization. I am hopeful that the outcomes of this collaboration will lead to a deeper understanding of gait pathology and progression in movement disorders with the potential to positively impact future therapies and the quality of life for patients with these conditions. I look forward to continuing to work with MC10 and the BioStamp nPoint system,” said Dr. McGinnis.
MC10 is a privately held company focused on improving human health through digital solutions. The company combines conformal BioStamp sensors with clinical analytics to unlock novel insights from physiological data collected from the home or in clinical settings. Our flagship product, BioStamp nPoint, is marketed into the clinical research community. MC10 is headquartered in Lexington, MA. Visit MC10 online at https://www.mc10inc.com or follow us on LinkedIn.
MC10®, BioStamp nPoint®, and the MC10 logo are registered marks owned by MC10, Inc.
About University of Vermont
Founded in 1791, the fifth oldest university in New England, the University of Vermont is a premier research university that places emphasis on undergraduate education. For much of its early history, UVM was a private liberal arts college. In 1865, it became Vermont’s land grant university, serving the needs of the state through the discovery and application of new knowledge. The modern UVM is a public university that combines both strands of its history, offering students a liberal arts-style education in a research university setting.